![]() |
Factsheet as on February 28, 2025 |
The investment objective of the scheme is to generate long term capital appreciation from a portfolio of equity and equity related securities, by investing predominantly in mid companies. The scheme may also invest in Debt and Money Market Instruments, as per the asset allocation table. There is no assurance that the investment objective of the Scheme will be achieved.
1 Year | 2 Years | 3 Years | 5 Years | |
Scheme (%) | 6.74 | 20.19 | 16.50 | 21.43 |
Nifty Midcap 100 (%) | -0.36 | 26.09 | 19.28 | 23.31 |
Company Name | % of Assets |
Fortis Healthcare Ltd. | 3.4 |
IPCA Laboratories Ltd. | 3.4 |
Mphasis Ltd. | 3.0 |
Coromandel International Ltd. (Coromandel Fertilisers Ltd.) | 2.9 |
Oberoi Realty Ltd. | 2.7 |
Oracle Financial Services Software Ltd. | 2.7 |
Persistent Systems Ltd. | 2.6 |
J. K. Cement Ltd. | 2.5 |
Dixon Technologies India Ltd. | 2.4 |
Wipro Ltd. | 2.3 |
Standard Deviation | 15.96 |
Beta | 0.97 |
Information Ratio | 0.17 |
Sharpe Ratio | 0.17 |
Kotak Mahindra Bank Limited, AMFI Registered Mutual Fund Distributor, ARN 1390
Kotak Mahindra Bank Limited, AMFI Registered Mutual Fund Distributor, ARN 1390